NICE recommends 3 treatments for COVID-19 in draft guidance

NICE

16 November 2022 - Three treatments for COVID have been recommended in draft NICE guidance released today for public consultation.

The recommended treatments are:

  • Nirmatrelvir and ritonavir (Paxlovid, Pfizer)
  • Tocilizumab (RoActemra, Roche)
  • Baricitinib (Olumiant, Eli Lilly, subject to it receiving a marketing authorisation in Great Britain for treating COVID-19)

Read NICE press release

Michael Wonder

Posted by:

Michael Wonder